Runx2 and dental development

European Journal of Oral Sciences

Volumn 114, Issue 5, 2006, Pages 361-373

  Camilleri, Simon ^a   McDonald, Fraser ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bone; Odontogenesis; Runx2; Tooth eruption

Indexed keywords

ISOPROTEIN; TRANSCRIPTION FACTOR RUNX2;

AMELOBLAST; ANIMAL; BONE DEVELOPMENT; CELL DIFFERENTIATION; CEMENTUM; CYTOLOGY; GENETICS; HUMAN; METABOLISM; MOUSE; ODONTOBLAST; OSTEOBLAST; OSTEOCLAST; PERIODONTAL LIGAMENT; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVIEW; TOOTH; TOOTH ERUPTION;

AMELOBLASTS; ANIMALS; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DENTAL CEMENTUM; HUMANS; MICE; ODONTOBLASTS; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; PERIODONTAL LIGAMENT; PROTEIN ISOFORMS; TOOTH; TOOTH ERUPTION;

EID: 33749516799     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/j.1600-0722.2006.00399.x     Document Type: Review

References (141)

1. MUNDLOS S, OTTO F, MUNDLOS C, MULLIKEN JB, AYLSWORTH AS, ALBRIGHT S, LINDHOUT D, COLE WG, HENN W, KNOLL JH, OWEN MJ, MERTELSMANN R, ZABEL BU, OLSEN BR. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997; 89: 773-779.
2. KOMORI T, YAGI H, NOMURA S, YAMAGUCHI A, SASAKI K, DEGUCHI K, SHIMIZU Y, BRONSON RT, GAO YH, INADA M, SATO M, OKAMOTO R, KITAMURA Y, YOSHIKI S, KISHIMOTO T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89: 755-764.
3. DUCY P, ZHANG R, GEOFFROY V, RIDALL AL, KARSENTY G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-754.
4. DUCY P, STARBUCK M, PRIEMEL M, SHEN J, PINERO G, GEOFFROY V, AMLING M, KARSENTY G. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 1999; 13: 1025-1036.
5. QUACK I, VONDERSTRASS B, STOCK M, AYLSWORTH AS, BECKER A, BRUETON L, LEE PJ, MAJEWSKI F, MULLIKEN JB, SURI M, ZENKER M, MUNDLOS S, OTTO F. Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia. Am J Hum Genet 1999; 65: 1268-1278.
6. D'SOUZA RN, ABERG T, GAIKWAD J, CAVENDER A, OWEN M, KARSENTY G, THESLEFF I. Cbfa1 is required for epithelial-mesenchymal interactions regulating tooth development in mice. Development 1999; 126: 2911-2920.
7. HITCHIN AD. Cementum and other root abnormalities of permanent teeth in cleidocranial dysostosis. Br Dent J 1975; 139: 313-318.
8. JENSEN BL, KREIBORG S. Development of the dentition in cleidocranial dysplasia. J Oral Pathol Med 1990; 19: 89-93.
9. LEVANON D, NEGREANU V, BERNSTEIN Y, BAR-AM I, AVIVI L, GRONER Y. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 1994; 23: 425-432.
10. XIAO ZS, THOMAS R, HINSON TK, QUARLES LD. Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. Gene 1998; 214: 187-197.
11. GEOFFROY V, CORRAL DA, ZHOU L, LEE B, KARSENTY G. Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function. Mamm Genome 1998; 9: 54-57.
12. KUNDU M, JAVED A, JEON JP, HORNER A, SHUM L, ECKHAUS M, MUENKE M, LIAN JB, YANG Y, NUCKOLLS GH, STEIN GS, LIU PP. Cbfbeta interacts with Runx2 and has a critical role in bone development. Nat Genet 2002; 32: 639-644.
13. YOSHIDA CA, FURUICHI T, FUJITA T, FUKUYAMA R, KANATANI N, KOBAYASHI S, SATAKE M, TAKADA K, KOMORI T. Corebinding factor beta interacts with Runx2 and is required for skeletal development. Nat Genet 2002; 32: 633-638.
14. ITO Y. Molecular basis of tissue-specific gene expression mediated by the Runt domain transcription factor PEBP2/CBF. Genes Cells 1999; 4: 685-696.
15. HUANG G, SHIGESADA K, ITO K, WEE HJ, YOKOMIZO T, ITO Y. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J 2001; 20: 723-733.
16. YOUNG MF, KERR JM, IBARAKI K, HEEGAARD AM, ROBEY PG. Structure, expression, and regulation of the major non-collagenous matrix proteins of bone. Clin Orthop Relat Res 1992; 281: 275-294.
17. ROBEY PG, FEDARKO NS, HEFFERAN TE, BIANCO P, VETTER UK, GRZESIK W, FRIEDENSTEIN A, VAN DER PG, MINTZ KP, YOUNG MF. Structure and molecular regulation of bone matrix proteins. J Bone Miner Res 1993; 8: S483-S487.
18. MACKIE EJ. Osteoblasts: novel roles in orchestration of skeletal architecture. Int J Biochem Cell Biol 2003; 35: 1301-1305.
19. YOUNG MF. Bone matrix proteins: more than markers. Calcif Tissue Int 2003; 72: 2-4.
20. HOROWITZ M. Matrix proteins versus cytokines in the regulation of osteoblast function and bone formation. Calcif Tissue Int 2003; 72: 5-7.
21. OTTO F, THORNELL AP, CROMPTON T, DENZEL A, GILMOUR KC, ROSEWELL IR, STAMP GW, BEDDINGTON RS, MUNDLOS S, OLSEN BR, SELBY PB, OWEN MJ. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997; 89: 765-771.
22. SHEVDE NK, BENDIXEN AC, MARUYAMA M, LI BL, BILLMIRE DA. Enhanced activity of osteoblast differentiation factor (PEBP2alphaA2/CBFa1) in affected sutural osteoblasts from patients with nonsyndromic craniosynostosis. Cleft Palate Craniofac J 2001; 38: 606-614.
23. GEOFFROY V, KNEISSEL M, FOURNIER B, BOYDE A, MATTHIAS P. High bone resorption in adult aging transgenic mice overexpressing Cbfa1/Runx2 in cells of the osteoblastic lineage. Mol Cell Biol 2002; 22: 6222-6233.
24. LIU W, TOYOSAWA S, FURUICHI T, KANATANI N, YOSHIDA C, LIU Y, HIMENO M, NARAI S, YAMAGUCHI A, KOMORI T. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 2001; 155: 157-166.
25. DRISSI H, LUC Q, SHAKOORI R, CHUVA DE SOUSA LS, CHOI JY, TERRY A, HU M, JONES S, NEIL JC, LIAN JB, STEIN JL, VAN WIJNEN AJ, STEIN GS. Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J Cell Physiol 2000; 184: 341-350.
26. CHRISTIANSEN M, KVEIBORG M, KASSEM M, CLARK BFC, RATTAN SIS. CBFA1 and topoisomerase I mRNA levels decline during cellular aging of human trabecular osteoblasts. J Gerontol A Biol Sci Med Sci 2000; 55: B194-B200.
27. FRANCESCHI RT, XIAO G, JIANG D, GOPALAKRISHNAN R, YANG S, REITH E. Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation. Connect Tissue Res 2003; 44: 109-116.
28. FRANCESCHI RT, XIAO G. Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J Cell Biochem 2003; 88: 446-454.
29. BAE SC, LEE YH. Phosphorylation, acetylation and ubiquitination: the molecular basis of RUNX regulation. Gene 2006; 366: 58-66.
30. ZHAO M, QIAO M, OYAJOBI BO, MUNDY GR, CHEN D. E3 ubiquitin ligase Smurf1 mediates core-binding factor {alpha}1/Runx2 degradation and plays a specific role in osteoblast differentiation. J Biol Chem 2003; 278: 27939-27944.
31. JEON EJ, LEE KY, CHOI NS, LEE MH, KIM HN, JIN YH, RYOO HM, CHOI JY, YOSHIDA M, NISHINO N, OH BC, LEE KS, LEE YH, BAE SC. Bone morphogenetic protein-2 stimulates RUNX2 acetylation. J Biol Chem 2006; 281; 16502-16511.
32. SHUI C, SPELSBERG TC, RIGGS BL, KHOSLA S. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res 2003; 18: 213-221.
33. DUCY P, KARSENTY G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 1995; 15: 1858-1869.
34. ZIROS PG, GIL AP, GEORGAKOPOULOS T, HABEOS I, KLETSAS D, BASDRA EK, PAPAVASSILIOU AG. The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells. J Biol Chem 2002; 277: 23934-23941.
35. ZAIDI SK, SULLIVAN AJ, VAN WIJNEN AJ, STEIN JL, STEIN GS, LIAN JB. Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc Natl Acad Sci USA 2002; 99: 8048-8053.
36. THIRUNAVUKKARASU K, MAHAJAN M, MCLARREN KW, STIFANI S, KARSENTY G. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta. Mol Cell Biol 1998; 18: 4197-4208.
37. ALBRECHT AN, KORNAK U, BODDRICH A, SURING K, ROBINSON PN, STIEGE AC, LURZ R, STRICKER S, WANKER EE, MUNDLOS S. A molecular pathogenesis for transcription factor associated poly-alanine tract expansions. Hum Mol Genet 2004; 13: 2351-2359.
38. ZHANG YW, YASUI N, ITO K, HUANG G, FUJII M, HANAI J, NOGAMI H, OCHI T, MIYAZONO K, ITO Y. A RUNX2/PEB-P2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci USA 2000; 97: 10549-10554.
39. SIERRA J, VILLAGRA A, PAREDES R, CRUZAT F, GUTIERREZ S, JAVED A, ARRIAGADA G, OLATE J, IMSCHENETZKY M, VAN WIJNEN AJ, LIAN JB, STEIN GS, STEIN JL, MONTECINO M. Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol Cell Biol 2003; 23: 3339-3351.
40. WESTENDORF JJ, ZAIDI SK, CASCINO JE, KAHLER R, VAN WIJNEN AJ, LIAN JB, YOSHIDA M, STEIN GS, LI X. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21 (CIP1/WAF1) promoter. Mol Cell Biol 2002; 22: 7982-7992.
41. MCLARREN KW, THERIAULT FM, STIFANI S. Association with the nuclear matrix and interaction with Groucho and RUNX proteins regulate the transcription repression activity of the basic helix loop helix factor Hes1. J Biol Chem 2001; 276: 1578-1584.
42. JAVED A, GUO B, HIEBERT S, CHOI JY, GREEN J, ZHAO SC, OSBORNE MA, STIFANI S, STEIN JL, LIAN JB, VAN WIJNEN AJ, STEIN GS. Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF (alpha)/AML/PEBP2 (alpha) dependent activation of tissue-specific gene transcription. J Cell Sci 2000; 113: 2221-2231.
43. FENRICK R, AMANN JM, LUTTERBACH B, WANG L, WESTENDORF JJ, DOWNING JR, HIEBERT SW. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein. Mol Cell Biol 1999; 19: 6566-6574.
44. ZAIDI SK, SULLIVAN AJ, MEDINA R, ITO Y, VAN WIJNEN AJ, STEIN JL, LIAN JB, STEIN GS. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J 2004; 23: 790-799.
45. WESTENDORF JJ. Transcriptional co-repressors of Runx2. J Cell Biochem 2006; 98: 54-64.
46. WANG W, WANG YG, REGINATO AM, GLOTZER DJ, FUKAI N, PLOTKINA S, KARSENTY G, OLSEN BR. Groucho homologue Grg5 interacts with the transcription factor Runx2-Cbfa1 and modulates its activity during postnatal growth in mice. Dev Biol 2004; 270: 364-381.
47. SCHROEDER TM, KAHLER RA, LI X, WESTENDORF JJ. Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. J Biol Chem 2004; 279: 41998-42007.
48. VEGA RB, MATSUDA K, OH J, BARBOSA AC, YANG X, MEADOWS E, MCANALLY J, POMAJZL C, SHELTON JM, RICHARDSON JA, KARSENTY G, OLSON EN. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004; 119: 555-566.
49. PELLETIER N, CHAMPAGNE N, STIFANI S, YANG XJ. MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. Oncogene 2002; 21: 2729-2740.
50. THOMAS DM, JOHNSON SA, SIMS NA, TRIVETT MK, SLAVIN JL, RUBIN BP, WARING P, MCARTHUR GA, WALKLEY CR, HOLLOWAY AJ, DIYAGAMA D, GRIM JE, CLURMAN BE, BOWTELL DD, LEE JS, GUTIERREZ GM, PISCOPO DM, CARTY SA, HINDS PW. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma. J Cell Biol 2004; 167: 925-934.
51. CUI CB, COOPER LF, YANG X, KARSENTY G, AUKHIL I. Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol Cell Biol 2003; 23: 1004-1013.
52. BIALEK P, KERN B, YANG X, SCHROCK M, SOSIC D, HONG N, WU H, YU K, ORNITZ DM, OLSON EN, JUSTICE MJ, KARSENTY G. A twist code determines the onset of osteoblast differentiation. Dev Cell 2004; 6: 423-435.
53. HARRINGTON KS, JAVED A, DRISSI H, MCNEIL S, LIAN JB, STEIN JL, VAN WIJNEN AJ, WANG YL, STEIN GS. Transcription factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate with stationary subnuclear domains. J Cell Sci 2002; 115: 4167-4176.
54. ZENG C, MCNEIL S, POCKWINSE S, NICKERSON J, SHOPLAND L, LAWRENCE JB, PENMAN S, HIEBERT S, LIAN JB, VAN WIJNEN AJ, STEIN JL, STEIN GS. Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domains. Proc Natl Acad Sci USA 1998; 95: 1585-1589.
55. ZAIDI SK, JAVED A, CHOI JY, VAN WIJNEN AJ, STEIN JL, LIAN JB, STEIN GS. A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J Cell Sci 2001; 114: 3093-3102.
56. JAVED A, BARNES GL, PRATAP J, ANTKOWIAK T, GERSTENFELD LC, VAN WIJNEN AJ, STEIN JL, LIAN JB, Stein GS. Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc Natl Acad Sci USA 2005; 102: 1454-1459.
57. XIAO ZS, HINSON TK, QUARLES LD. Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells. J Cell Biochem 1999; 74: 596-605.
58. BAE SC, OGAWA E, MARUYAMA M, OKA H, SATAKE M, SHIGESADA K, JENKINS NA, GILBERT DJ, COPELAND NG, ITO Y. PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol Cell Biol 1994; 14: 3242-3252.
59. BANERJEE C, JAVED A, CHOI JY, GREEN J, ROSEN V, VAN WIJNEN AJ, STEIN JL, LIAN JB, STEIN GS. Differential regulation of the two principal Runx2/Cbfa1 N-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 2001; 142: 4026-4039.
60. HARADA H, TAGASHIRA S, FUJIWARA M, OGAWA S, KATSUMATA T, YAMAGUCHI A, KOMORI T, NAKATSUKA M. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 1999; 274: 6972-6978.
61. PARK MH, SHIN HI, CHOI JY, NAM SH, KIM YJ, KIM HJ, RYOO HM. Differential expression patterns of Runx2 isoforms in cranial suture morphogenesis. J Bone Miner Res 2001; 16: 885-892.
62. XIAO ZS, HJELMELAND AB, QUARLES LD. Selective deficiency of the 'bone-related' Runx2-II unexpectedly preserves osteoblast-mediated skeletogenesis. J Biol Chem 2004; 279: 20307-20313.
63. CHOI KY, LEE SW, PARK MH, BAE YC, SHIN HI, NAM S, KIM YJ, KIM HJ, RYOO HM. Spatio-temporal expression patterns of Runx2 isoforms in early skeletogenesis. Exp Mol Med 2002; 34: 426-433.
64. CHOI KY, KIM HJ, LEE MH, KWON TG, NAH HD, FURUICHI T, KOMORI T, NAM SH, KIM YJ, KIM HJ, RYOO HM. Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development. Dev Dyn 2005; 233: 115-121.
65. LEE MH, KIM YJ, YOON WJ, KIM JI, KIM BG, HWANG YS, WOZNEY JM, CHI XZ, BAE SC, CHOI KY, CHO JY, CHOI JY, RYOO HM. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem 2005; 280: 35579-35587.
66. CHEN S, GU TT, SREENATH T, KULKARNI AB, KARSENTY G, MACDOUGALL M. Spatial expression of Cbfa1/Runx2 isoforms in teeth and characterization of binding sites in the DSPP gene. Connect Tissue Res 2002; 43: 338-344.
67. KOBAYASHI I, KIYOSHIMA T, WADA H, MATSUO K, NONAKA K, HONDA JY, KOYANO K, SAKAI H. Type II/III Runx2/Cbfa1 is required for tooth germ development. Bone 2006; 38: 836-844.
68. XIAO ZS, SIMPSON LG, QUARLES LD. IRES-dependent translational control of Cbfa1/Runx2 expression. J Cell Biochem 2003; 88: 493-505.
69. STEWART M, TERRY A, HU M, O'HARA M, BLYTH K, BAXTER E, CAMERON E, ONIONS DE, NEIL JC. Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. Proc Natl Acad Sci USA 1997; 94: 8646-8651.
70. TERRY A, KILBEY A, VAILLANT F, STEWART M, JENKINS A, CAMERON E, NEIL JC. Conservation and expression of an alternative 3′ exon of Runx2 encoding a novel proline-rich C-terminal domain. Gene 2004; 336: 115-125.
71. MANOLAGAS SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000; 21: 115-137.
72. GORI F, HOFBAUER LC, DUNSTAN CR, SPELSBERG TC, KHOSLA S, RIGGS BL. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromalosteoblast lineage cells is developmentally regulated. Endocrinology 2000; 141: 4768-4776.
73. GAO YH, SHINKI T, YUASA T, KATAOKA-ENOMOTO H, KOMORI T, SUDA T, YAMAGUCHI A. Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF). Biochem Biophys Res Commun 1998; 252: 697-702.
74. ENOMOTO H, SHIOJIRI S, HOSHI K, FURUICHI T, FUKUYAMA R, YOSHIDA CA, KANATANI N, NAKAMURA R, MIZUNO A, ZANMA A, YANO K, YASUDA H, HIGASHIO K, TAKADA K, KOMORI T. Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene. J Biol Chem 2003; 278: 23971-23977.
75. THIRUNAVUKKARASU K, HALLADAY DL, MILES RR, YANG X, GALVIN RJ, CHANDRASEKHAR S, MARTIN TJ, ONYIA JE. The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. J Biol Chem 2000; 275: 25163-25172.
76. THIRUNAVUKKARASU K, MILES RR, HALLADAY DL, YANG X, GALVIN RJS, CHANDRASEKHAR S, MARTIN TJ, ONYIA JE. Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects. J Biol Chem 2001; 276: 36241-36250.
77. KITAZAWA R, KITAZAWA S, MAEDA S. Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene. Biochim Biophys Acta 1999; 1445: 134-141.
78. O'BRIEN CA, KERN B, GUBRIJ I, KARSENTY G, MANOLAGAS SC. Cbfa1 does not regulate RANKL gene activity in stromal/osteoblastic cells. Bone 2002; 30: 453-462.
79. NOTOYA M, OTSUKA E, YAMAGUCHI A, HAGIWARA H. Runx-2 is not essential for the vitamin d-regulated expression of RANKL and osteoprotegerin in osteoblastic cells. Biochem Biophys Res Commun 2004; 324: 655-660.
80. BLAIR HC, ROBINSON LJ, ZAIDI M. Osteoclast signalling pathways. Biochem Biophys Res Commun 2005; 328: 728-738.
81. JIANG H, SODEK J, KARSENTY G, THOMAS H, RANLY D, CHEN J. Expression of core binding factor Osf2/Cbfa-1 and bone sialoprotein in tooth development. Mech Dev 1999; 81: 169-173.
82. OHAZAMA A, COURTNEY JM, SHARPE PT. Opg, Rank, and Rankl in tooth development: co-ordination of odontogenesis and osteogenesis. J Dent Res 2004; 83: 241-244.
83. ABERG T, WANG XP, KIM JH, YAMASHIRO T, BEI M, RICE R, RYOO HM, THESLEFF I. Runx2 mediates FGF signaling from epithelium to mesenchyme during tooth morphogenesis. Dev Biol 2004; 270: 76-93.
84. ABERG T, CAVENDER A, GAIKWAD JS, BRONCKERS ALJJ, WANG X, WALTIMO-SIREN J, THESLEFF I, D'SOUZA RN. Phenotypic changes in dentition of Runx2 homozygote-null mutant mice. J Histochem Cytochem 2004; 52: 131-140.
85. THOMAS BL, TUCKER AS, QUI M, FERGUSON CA, HARDCASTLE Z, RUBENSTEIN JL, SHARPE PT. Role of Dlx-1 and Dlx-2 genes in patterning of the murine dentition. Development 1997; 124: 4811-4818.
86. FERGUSON CA, TUCKER AS, CHRISTENSEN L, LAU AL, MATZUK MM, SHARPE PT. Activin is an essential early mesenchymal signal in tooth development that is required for patterning of the murine dentition. Genes Dev 1998; 12: 2636-2649.
87. WANG XP, ABERG T, JAMES MJ, LEVANON D, GRONER Y, THESLEFF I. Runx2 (Cbfa1) inhibits Shh signaling in the lower but not upper molars of mouse embryos and prevents the budding of putative successional teeth. J Dent Res 2005; 84: 138-143.
88. BRONCKERS AL, ENGELSE MA, CAVENDER A, GAIKWAD J, D'SOUZA RN. Cell-specific patterns of Cbfa1 mRNA and protein expression in postnatal murine dental tissues. Mech Dev 2001; 101: 255-258.
89. DHAMIJA S, KREBSBACH PH. Role of Cbfa1 in ameloblastin gene transcription. J Biol Chem 2001; 276: 35159-35164.
90. FUKUTA Y, TOTSUKA M, FUKUTA Y, TAKEDA Y, YOSHIDA Y, NIITSU J, YAMAMOTO H. Histological and analytical studies of a tooth in a patient with cleidocranial dysostosis. J Oral Sci 2001; 43: 85-89.
91. YAMAMOTO H, SAKAE T, DAVIES JE. Cleidocranial dysplasia: a light microscope, electron microscope, and crystallographic study. Oral Surg Oral Med Oral Pathol 1989; 68: 195-200.
92. LUKINMAA PL, JENSEN BL, THESLEFF I, ANDREASEN JO, KREIBORG S. Histological observations of teeth and peridental tissues in cleidocranial dysplasia imply increased activity of odontogenic epithelium and abnormal bone remodeling. J Craniofac Genet Dev Biol 1995; 15: 212-221.
93. QIN C, BRUNN JC, CADENA E, RIDALL A, TSUJIGIWA H, NAGATSUKA H, NAGAI N, BUTLER WT. The expression of dentin sialophosphoprotein gene in bone. J Dent Res 2002; 81: 392-394.
94. BABA O, QIN C, BRUNN JC, JONES JE, WYGANT JN, MCINTYRE BW, BUTLER WT. Detection of dentin sialoprotein in rat periodontium. Eur J Oral Sci 2004; 112: 163-170.
95. CHEN S, RANI S, WU Y, UNTERBRINK A, GU TT, GLUHAK-HEINRICH J, CHUANG HH, MACDOUGALL M. Differential regulation of dentin sialophosphoprotein expression by Runx2 during odontoblast cytodifferentiation. J Biol Chem 2005; 280: 29717-29727.
96. NARAYANAN K, SRINIVAS R, RAMACHANDRAN A, HAO J, QUINN B, GEORGE A. Differentiation of embryonic mesenchymal cells to odontoblast-like cells by overexpression of dentin matrix protein 1. Proc Natl Acad Sci USA 2001; 98: 4516-4521.
97. FEN JQ, ZHANG J, DALLAS SL, LU Y, CHEN S, TAN X, OWEN M, HARRIS SE, MACDOUGALL M. Dentin matrix protein 1, a target molecule for Cbfa1 in bone, is a unique bone marker gene. J Bone Miner Res 2002; 17: 1822-1831.
98. CHEN S, SANTOS L, WU Y, VUONG R, GAY I, SCHULZE J, CHUANG HH, MACDOUGALL M. Altered gene expression in human cleidocranial dysplasia dental pulp cells. Arch Oral Biol 2005; 50: 227-236.
99. LIU H, LI W, SHI S, HABELITZ S, GAO C, DENBESTEN P. MEPE is downregulated as dental pulp stem cells differentiate. Arch Oral Biol 2005; 50: 923-928.
100. YAMASHIRO T, ABERG T, LEVANON D, GRONER Y, THESLEFF I. Expression of Runx1, -2 and -3 during tooth, palate and craniofacial bone development. Mech Dev 2002; 119: S107-S110.
101. GAIKWAD JS, HOFFMANN M, CAVENDER A, BRONCKERS AL, D'SOUZA RN. Molecular insights into the lineage-specific determination of odontoblasts: the role of Cbfa1. Adv Dent Res 2001; 15: 19-24.
102. BOSSHARDT DD. Are cementoblasts a subpopulation of osteoblasts or a unique phenotype? J Dent Res 2005; 84: 390-406.
103. DARD M. Histology of alveolar bone and primary tooth roots in a case of cleidocranial dysplasia. Bull Group Int Rech Sci Stomatol Odontol 1993; 36: 101-107.
104. ZOU SJ, D'SOUZA RN, AHLBERG T, BRONCKERS AL. Tooth eruption and cementum formation in the Runx2/Cbfa1 heterozygous mouse. Arch Oral Biol 2003; 48: 673-677.
105. CHUNG CR, TSUJI K, NIFUJI A, KOMORI T, SOMA K, NODA M. Micro-CT evaluation of tooth, calvaria and mechanical stress-induced tooth movement in adult Runx2/Cbfa1 heterozygous knock-out mice. J Med Dent Sci 2004; 51: 105-113.
106. SEOW WK, Hertzberg J. Dental development and molar root length in children with cleidocranial dysplasia. Pediatr Dent 1995; 17: 101-105.
107. HITCHIN AD, FAIRLEY JM. Dental management in cleidocranial dysostosis. Br J Oral Surg 1974; 12: 46-55.
108. MCNAMARA CM, O'RIORDAN BC, BLAKE M, SANDY JR. Cleidocranial dysplasia: radiological appearances on dental panoramic radiography. Dentomaxillofac Radiol 1999; 28: 89-97.
109. SAITO M, IWASE M, MASLAN S, NOZAKI N, YAMAUCHI M, HANDA K, TAKAHASHI O, SATO S, KAWASE T, TERANAKA T, NARAYANAN AS. Expression of cementum-derived attachment protein in bovine tooth germ during cementogenesis. Bone 2001; 29: 242-248.
110. KATO C, KOJIMA T, KOMAKI M, MIMORI K, DUARTE WR, TAKENAGA K, ISHIKAWA I. S100A4 inhibition by RNAi up-regulates osteoblast related genes in periodontal ligament cells. Biochem Biophys Res Commun 2004; 326: 147-153.
111. YANG YQ, LI XT, RABIE AB, FU MK, ZHANG D. Human periodontal ligament cells express osteoblastic phenotypes under intermittent force loading in vitro. Front Biosci 2006; 11: 776-781.
112. SHAIKH R, SHUSTERMAN S. Delayed dental maturation in cleidocranial dysplasia. ASDC J Dent Child 1998; 65: 355.
113. YODA S, SUDA N, KITAHARA Y, KOMORI T, OHYAMA K. Delayed tooth eruption and suppressed osteoclast number in the eruption pathway of heterozygous Runx2/Cbfa1 knockout mice. Arch Oral Biol 2004; 49: 435-442.
114. RICHARDSON A, DEUSSEN FF. Facial and dental anomalies in cleidocranial dysplasia: a study of 17 cases. Int J Paediatr Dent 1994; 4: 225-231.
115. JENSEN BL, KREIBORG S. Dental treatment strategies in cleidocranial dysplasia. Br Dent J 1992; 172: 243-247.
116. JENSEN BL. Somatic development in cleidocranial dysplasia. Am J Med Genet 1990; 35: 69-74.
117. LEVIN EJ, SONNENSCHEIN H. Cleidocranial dysostosis. N Y State J Med 1963; 63: 1562-1566.
118. ISHII K, NIELSEN IL, VARGERVIK K. Characteristics of jaw growth in cleidocranial dysplasia. Cleft Palate Craniofac J 1998; 35: 161-166.
119. SUZUKI T, SUDA N, OHYAMA K. Osteoclastogenesis during mouse tooth germ development is mediated by receptor activator of NFKappa-B ligand (RANKL). J Bone Miner Metab 2004; 22: 185-191.
120. HEINRICH J, BSOUL S, BARNES J, WOODRUFF K, ABBOUD S. CSF-1, RANKL and OPG regulate osteoclastogenesis during murine tooth eruption. Arch Oral Biol 2005; 50: 897-908.
121. GAO Y, KOBAYASHI H, GANSS B. The human KROX-26/ZNF22 gene is expressed at sites of tooth formation and maps to the locus for permanent tooth agenesis (He-Zhao deficiency). J Dent Res 2003; 82: 1002-1007.
122. DANN JJ III, CRUMP P, RINGENBERG QM. Vertical maxillary deficiency with cleidocranial dysplasia. Diagnostic findings and surgical-orthodontic correction. Am J Orthod 1980; 78: 564-574.
123. PETROPOULOS VC, BALSHI TJ, BALSHI SF, WOLFINGER GJ. Treatment of a patient with cleidocranial dysplasia using osseointegrated implants: a patient report. Int J Oral Maxillofac Implants 2004; 19: 282-287.
124. BECKER A, LUSTMANN J, SHTEYER A. Cleidocranial dysplasia: Part 1 - General principles of the orthodontic and surgical treatment modality. Am J Orthod Dentofacial Orthop 1997; 111: 28-33.
125. HARDT N. Osteo-dental dysplasia with poly- and hypodontia in cleidocranial dysostosis. Quintessenz 1973; 24: 105-111.
126. BAUMERT U, GOLAN I, REDLICH M, AKNIN JJ, MUESSIG D. Cleidocranial dysplasia: molecular genetic analysis and phenotypic-based description of a Middle European patient group. Am J Med Genet 2005; 139: 78-85.
127. YOSHIDA T, KANEGANE H, OSATO M, YANAGIDA M, MIYAWAKI T, ITO Y, SHIGESADA K. Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations. Am J Hum Genet 2002; 71: 724-738.
128. YOSHIDA T, KANEGANE H, OSATO M, YANAGIDA M, MIYAWAKI T, ITO Y, SHIGESADA K. Functional analysis of RUNX2 mutations in cleidocranial dysplasia: novel insights into genotype-phenotype correlations. Blood Cells Mol Dis 2003; 30: 184-193.
129. TESSA A, SALVI S, CASALI C, GARAVELLI L, DIGILIO MC, DOTTI MT, DI GIANDOMENICO S, VALOPPI M, GRIECO GS, COMANDUCCI G, BIANCHINI G, FORTINI D, FEDERICO A, GIANNOTTI A, SANTORELLI FM. Six novel mutations of the RUNX2 gene in Italian patients with cleidocranial dysplasia. Hum Mutat 2003; 22: 104.
130. ZHOU G, CHEN Y, ZHOU L, THIRUNAVUKKARASU K, HECHT J, CHITAYAT D, GELB BD, PIRINEN S, BERRY SA, GREENBERG CR, KARSENTY G, LEE B. CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. Hum Mol Genet 1999; 8: 2311-2316.
131. COBOURNE MT, HARDCASTLE Z, SHARPE PT. Sonic hedgehog regulates epithelial proliferation and cell survival in the developing tooth germ. J Dent Res 2001; 80: 1974-1979.
132. COBOURNE MT, MILETICH I, SHARPE PT. Restriction of sonic hedgehog signalling during early tooth development. Development 2004; 131: 2875-2885.
133. PRATAP J, GALINDO M, ZAIDI SK, VRADII D, BHAT BM, ROBINSON JA, CHOI JY, KOMORI T, STEIN JL, LIAN JB, STEIN GS, VAN WIJNEN AJ. Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts. Cancer Res 2003; 63: 5357-5362.
134. RAMESAR RS, GREENBERG J, MARTIN R, GOLIATH R, BARDIEN S, MUNDLOS S, BEIGHTON P. Mapping of the gene for cleidocranial dysplasia in the historical Cape Town (Arnold) kindred and evidence for locus homogeneity. J Med Genet 1996; 33: 511-514.
135. GELB BD, COOPER E, SHEVELL M, DESNICK RJ. Genetic mapping of the cleidocranial dysplasia (CCD) locus on chromosome band 6p21 to include a microdeletion. Am J Med Genet 1995; 58: 200-205.
136. FELDMAN GJ, ROBIN NH, BRUETON LA, ROBERTSON E, THOMPSON EM, SIEGEL-BARTELT J, GASSER DL, BAILEY LC, ZACKAI EH, MUENKE M. A gene for cleidocranial dysplasia maps to the short arm of chromosome 6. Am J Hum Genet 1995; 56: 938-943.
137. MUNDLOS S, MULLIKEN JB, ABRAMSON DL, WARMAN ML, KNOLL JH, OLSEN BR. Genetic mapping of cleidocranial dysplasia and evidence of a microdeletion in one family. Hum Mol Genet 1995; 4: 71-75.
138. NAPIERALA D, GARCIA-ROJAS X, SAM K, WAKUI K, CHEN C, MENDOZA-LONDONO R, ZHOU G, ZHENG Q, LEE B. Mutations and promoter SNPs in RUNX2, a transcriptional regulator of bone formation. Mol Genet Metab 2005; 86: 257-268.
139. DOECKE JD, DAY CJ, STEPHENS AS, CARTER SL, VAN DAAL A, KOTOWICZ MA, NICHOLSON GC, MORRISON NA. Association of functionally different RUNX2 P2 promoter alleles with BMD. J Bone Miner Res 2006; 21: 265-273.
140. BAE SC, CHOI JK. Tumor suppressor activity of RUNX3. Oncogene 2004; 23: 4336-4340.
141. LI QL, KIM HR, KIM WJ, CHOI JK, LEE YH, KIM HM, LI LS, KIM H, CHANG J, ITO Y, YOUL LK, BAE SC. Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun 2004; 314: 223-228.